About
CorRen is developing an autonomous, hands-free Ankle Brachial Index (ABI) test for detecting Peripheral Artery Disease (PAD). The worldwide market potential for ABI testing equipment stands at $1.6B. Existing ABI testing methods face challenges of complexity and time constraints. CorRen's UltraSense is designed to bridge this gap, providing an accurate, user-friendly, and reimbursable solution that has the potential to revolutionize PAD diagnosis and treatment.
Technologies
OutlookBlue HostGoogle Font APINginxMobile FriendlyGoogle Tag ManagerApachereCAPTCHAWordPress.org
Keywords
medical equipment manufacturinglow flow detectionreliable ultrasoundhealthcare technologyultrasound systemdiagnostic accuracyprocedure efficiencymedical imaging softwarestochastic resonance ultrasoundclinical diagnosticsmedical staff trainingsignal boostinghands-free ultrasounddisruptive ultrasound innovationvessel locationmedical device developmentvascular disease detectionautomated vessel localizationsignal enhancementtelemedicinemedical deviceultrasound signal analysismedical device innovationdiagnostic reportultrasound signal amplificationai-driven pad screeningcost reductionmedical devicesmedical equipment and supplies manufacturinghealthcare analytics
Company Information
- Employees7
- Founded2022
Location
Loma Linda, California, United States
